A simple and fast LC-MS/MS method for the simultaneous determination of tenofovir alafenamide and tenofovir in human plasma.
Xiaoping QianQi ChenYunhui ChenShiliang JiYing WangYe SunHuixin QiKan ZhongJinfang JiangXin ChenLifeng HuangYong YangPublished in: Biomedical chromatography : BMC (2021)
A simple and fast liquid chromatography-tandem mass spectrometry method was established and validated for the simultaneous determination of tenofovir alafenamide (TAF) and tenofovir (TNF) in human plasma. A simple protein precipitation procedure was employed to extract analytes from plasma. Chromatographic separation was performed on an Eclipse Plus C18 column utilizing a fast gradient elution starting with 2% of 2 mM ammonium acetate-formic acid (100/0.1, v/v) followed by increasing the percentage of acetonitrile. Detection was performed on a tandem mass spectrometer equipped with an electrospray ionization source operated in the positive ionization mode, using the transitions m/z 477.2 → m/z 346.1 for TAF and m/z 288.1 → m/z 176.1 for TNF. TAF-d5 and TNF-d7 were used as the internal standard of TAF and TNF, respectively. The method was validated in the concentration ranges 1.25-500 ng/mlfor TAF and 0.300-15.0 ng/ml for TNF with acceptable accuracy and precision.
Keyphrases
- simultaneous determination
- liquid chromatography tandem mass spectrometry
- liquid chromatography
- rheumatoid arthritis
- tandem mass spectrometry
- high performance liquid chromatography
- solid phase extraction
- ultra high performance liquid chromatography
- mass spectrometry
- antiretroviral therapy
- high resolution mass spectrometry
- gas chromatography
- high resolution
- oxidative stress
- quantum dots
- anti inflammatory
- binding protein
- protein protein